Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising awareness of animal welfare
3.2.1.2 Increasing pet ownership
3.2.1.3 Development of novel therapeutics
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Adverse effects and safety concerns
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 NSAIDs
5.3 Anesthetics
5.4 Opioids
5.5 Alpha-2 agonists
5.6 Other drug classes
Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Oral
6.3 Parenteral
6.4 Topical
Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Dogs
7.3 Cats
7.4 Other animal types
Chapter 8 Market Estimates and Forecast, By Indication, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Orthopedic surgery
8.3 Soft tissue surgery
8.4 Dental surgery
8.5 Oncologic surgery
8.6 Other surgeries
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Veterinary hospital pharmacies
9.3 Retail pharmacies
9.4 Online pharmacies
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Assisi Animal Health
11.2 Bayer AG
11.3 Bimeda Animal Health
11.4 Boehringer Ingelheim International GmbH
11.5 Ceva Sante Animale
11.6 Chanelle Pharma Group
11.7 Dechra Pharmaceuticals
11.8 Elanco Animal Health Incorporated
11.9 Merck Animal Health
11.10 Norbrook
11.11 SAVA Vet
11.12 Vetoquinol S.A.
11.13 Virbac Group
11.14 Zoetis Inc.
